SCHEMBL4885889

SCHEMBL4885889

CCOc1ccc(F)c(B(c2c(F)ccc(OCC)c2F)c2c(F)ccc(OCC)c2F)c1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.42
FGFR2 P21802 1/20 0.40
KDM1A O60341 2/20 0.39
HTT P42858 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
TUBB1 Q9H4B7 1/20 0.36
ALDH1A1 P00352 5/20 0.35
NQO1 P15559 1/20 0.34
KDM4E B2RXH2 2/20 0.34
MAPT P10636 2/20 0.34
GAA P10253 1/20 0.34
ATM Q13315 1/20 0.34
HPGD P15428 3/20 0.33
POLB P06746 2/20 0.33
TSHR P16473 2/20 0.33
HSD17B10 Q99714 2/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1069183 0.87 L3MBTL1 (0.39) L3MBTL1FGFR2KDM1AHTTCYP1A2
SCHEMBL24240291 0.83 L3MBTL1 (0.47) L3MBTL1FGFR2KDM1AHTTCYP1A2
SCHEMBL17527769 0.82 L3MBTL1 (0.48) L3MBTL1FGFR2KDM1AHTTCYP1A2
SCHEMBL4884975 0.78 HTT (0.37) L3MBTL1FGFR2KDM1AHTTCYP1A2
SCHEMBL4405598 0.78 ALDH1A1 (0.45) L3MBTL1FGFR2KDM1AHTTCYP1A2
SCHEMBL13125478 0.78 L3MBTL1 (0.43) L3MBTL1FGFR2KDM1AHTTCYP1A2
SCHEMBL4889113 0.77 TUBB1 (0.40) L3MBTL1KDM1AHTTTDP1TUBB1
SCHEMBL1008554 0.76 L3MBTL1 (0.42) L3MBTL1FGFR2KDM1AHTTCYP1A2
SCHEMBL16855852 0.74 L3MBTL1 (0.42) L3MBTL1FGFR2KDM1ACYP1A2CYP2D6
SCHEMBL16769037 0.74 KDM4E (0.52) L3MBTL1CYP1A2CYP2D6CYP2C19TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1817318-B1 STABILIZING METHOD AND STABILIZED COMPOSITION FOR ARYL BORON COMPOUNDS NIPPON CATALYTIC CHEM IND (JP) 2013-08-28 EP disclosed
US-20080154065-A1 Stabilizing Method and Stabilized Composition for Aryl Boron Compounds NIPPON SHOKUBAI CO., LTD. (JP) 2008-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080154065-A1 Stabilizing Method and Stabilized Composition for Aryl Boron Compounds AR, AHR, BCL6 L3MBTL1 2660/4885FGFR2 588/4885KDM1A 476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.